"An investigational anti-HIV antibody delivered intravenously once every eight weeks safely and effectively prevented acquisition of HIV strains sensitive to that antibody, but did not significantly...
Read More
Chris Beyrer, Patrick Sullivan, Adaora A Adimora, Kenneth Mayer "President-elect Joe Biden and Vice President-elect Kamala Harris were elected at an extraordinary moment in US history, with the...
Read More"The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced the clinical investigators and institutions that will lead four NIH HIV...
Read More
"A pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every eight weeks was safe and more effective than a daily oral...
Read More
"New NIAID-funded research answers longstanding questions about key steps in HIV replication. The scientists who conducted the research are the first to create an environment in a test tube where they...
Read More
